A. O. B. Redmond

777 total citations
30 papers, 561 citations indexed

About

A. O. B. Redmond is a scholar working on Pulmonary and Respiratory Medicine, Nutrition and Dietetics and Psychiatry and Mental health. According to data from OpenAlex, A. O. B. Redmond has authored 30 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 5 papers in Nutrition and Dietetics and 5 papers in Psychiatry and Mental health. Recurrent topics in A. O. B. Redmond's work include Cystic Fibrosis Research Advances (18 papers), Child Nutrition and Feeding Issues (5 papers) and Child Nutrition and Water Access (3 papers). A. O. B. Redmond is often cited by papers focused on Cystic Fibrosis Research Advances (18 papers), Child Nutrition and Feeding Issues (5 papers) and Child Nutrition and Water Access (3 papers). A. O. B. Redmond collaborates with scholars based in United Kingdom, Netherlands and Czechia. A. O. B. Redmond's co-authors include Harry Shwachman, Kon‐Taik Khaw, J.A. Dodge, J. D. L. Hansen, J.S. Elborn, D. J. H. Brock, Iain McIntosh, Roberta J. Ward, J. D. Biggart and Dan G. O’Neill and has published in prestigious journals such as PEDIATRICS, Journal of Antimicrobial Chemotherapy and Alimentary Pharmacology & Therapeutics.

In The Last Decade

A. O. B. Redmond

29 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. O. B. Redmond United Kingdom 16 362 120 96 75 69 30 561
Tamarah Katz Australia 16 561 1.5× 161 1.3× 134 1.4× 61 0.8× 181 2.6× 34 826
Anita Laxova United States 5 660 1.8× 53 0.4× 50 0.5× 103 1.4× 25 0.4× 5 733
W. Theodore Bruns United States 10 760 2.1× 44 0.4× 85 0.9× 93 1.2× 40 0.6× 13 968
Khin M. Gyi United Kingdom 12 575 1.6× 44 0.4× 39 0.4× 130 1.7× 143 2.1× 14 806
Abraham Mizrahi United States 8 141 0.4× 37 0.3× 230 2.4× 81 1.1× 211 3.1× 8 407
Sheila G. McKenzie Switzerland 11 890 2.5× 51 0.4× 29 0.3× 102 1.4× 133 1.9× 14 1.1k
Antônio Fernando Ribeiro Brazil 14 455 1.3× 46 0.4× 24 0.3× 84 1.1× 119 1.7× 47 650
Margaret Kloster United States 15 604 1.7× 43 0.4× 27 0.3× 125 1.7× 42 0.6× 26 685
Alfredo Larrosa‐Haro Mexico 12 81 0.2× 40 0.3× 128 1.3× 79 1.1× 234 3.4× 65 513
George Kremenopoulos Greece 15 142 0.4× 29 0.2× 34 0.4× 214 2.9× 34 0.5× 24 719

Countries citing papers authored by A. O. B. Redmond

Since Specialization
Citations

This map shows the geographic impact of A. O. B. Redmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. O. B. Redmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. O. B. Redmond more than expected).

Fields of papers citing papers by A. O. B. Redmond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. O. B. Redmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. O. B. Redmond. The network helps show where A. O. B. Redmond may publish in the future.

Co-authorship network of co-authors of A. O. B. Redmond

This figure shows the co-authorship network connecting the top 25 collaborators of A. O. B. Redmond. A scholar is included among the top collaborators of A. O. B. Redmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. O. B. Redmond. A. O. B. Redmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Redmond, A. O. B., et al.. (2004). Energy balance in cystic fibrosis when stable and during a respiratory exacerbation. Clinical Nutrition. 23(6). 1405–1412. 15 indexed citations
2.
Redmond, A. O. B., et al.. (2001). Total energy expenditure in stable patients with cystic fibrosis. Clinical Nutrition. 20(3). 235–241. 18 indexed citations
3.
McCaughan, John, et al.. (2001). Clinical outcome after acquisition ofBurkholderia cepacia in patients with cystic fibrosis. Irish Journal of Medical Science (1971 -). 170(1). 28–31. 23 indexed citations
4.
Redmond, A. O. B., et al.. (1998). Oral Ciprofloxacin in the Treatment of Pseudomonas Exacerbations of Paediatric Cystic Fibrosis: Clinical Efficacy and Safety Evaluation Using Magnetic Resonance Image Scanning. Journal of International Medical Research. 26(6). 304–312. 19 indexed citations
5.
Redmond, A. O. B., et al.. (1997). Coexistence of cystic fibrosis and phenylketonuria.. PubMed. 66(1). 59–61.
6.
Patrick, Christian C., Alison G. Freifeld, Stephen Green, et al.. (1997). Panel discussion: ciprofloxacin/quinolone use in non-cystic fibrosis patients. The Pediatric Infectious Disease Journal. 16(1). 160–162. 2 indexed citations
7.
Redmond, A. O. B.. (1997). Risk-benefit experience of ciprofloxacin use in pediatric patients in the United Kingdom. The Pediatric Infectious Disease Journal. 16(1). 147–149. 15 indexed citations
8.
Hughes, David J., Alison Hill, Milan Maçek, et al.. (1996). Mutation characterization ofCFTR gene in 206 Northern Irish CF families: Thirty mutations, including two novel, account for 94% of CF chromosomes. Human Mutation. 8(4). 340–347. 18 indexed citations
9.
Hughes, David J., Alison Hill, Milan Maçek, et al.. (1996). Mutation characterization of CFTR gene in 206 Northern Irish CF families: Thirty mutations, including two novel, account for 94% of CF chromosomes. Human Mutation. 8(4). 340–347. 1 indexed citations
10.
Hughes, David J., Alison Hill, A. O. B. Redmond, N. C. Nevin, & Colin A. Graham. (1995). Fluorescent multiplex microsatellites used to identify haplotype associations with 15 CFTR mutations in 124 Northern Irish CF families. Human Genetics. 95(4). 462–4. 6 indexed citations
11.
Morrison, Joe, et al.. (1992). Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Alimentary Pharmacology & Therapeutics. 6(5). 549–555. 18 indexed citations
12.
Redmond, A. O. B., et al.. (1991). Evaluation of the PEP Mask in Cystic Fibrosis. Acta Paediatrica. 80(1). 51–56. 39 indexed citations
13.
Wilson, D C & A. O. B. Redmond. (1990). An unusual cause of thoracic mass.. Archives of Disease in Childhood. 65(9). 991–992. 16 indexed citations
14.
Scott, E. M., et al.. (1989). Clinical and pharmacokinetic aspects of ciprofloxacin in the treatment of acute exacerbations of pseudomonas infection in cystic fibrosis patients. Journal of Antimicrobial Chemotherapy. 24(5). 787–795. 11 indexed citations
15.
Nevin, N. C., et al.. (1981). Detection of cystic fibrosis homozygotes and heterozygotes by serum isoelectrofocusing. Human Genetics. 56(3). 387–389. 15 indexed citations
16.
Redmond, A. O. B.. (1980). Gastrointestinal complications in cystic fibrosis.. PubMed. 224(1341). 295–9. 2 indexed citations
17.
Shiner, M, A. O. B. Redmond, & J. D. L. Hansen. (1973). The jejunal mucosa in protein-energy malnutrition. A clinical, histological, and ultrastructural study. Experimental and Molecular Pathology. 19(1). 61–78. 27 indexed citations
18.
Novis, B. H., et al.. (1971). The value of estimating urinary indican.. PubMed. 45(41). 1167–70. 2 indexed citations
19.
Redmond, A. O. B., I. J. Carré, J. D. Biggart, & D. W. R. Mackenzie. (1965). Aspergillosis (Aspergillus nidulans) involving bone. The Journal of Pathology and Bacteriology. 89(1). 391–395. 41 indexed citations
20.
Redmond, A. O. B., J. H. Robertson, & Mark Nelson. (1963). Familial Hypochromic Anaemia with Hyperferricaemia. BMJ. 2(5349). 89–93. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026